Synthesis of N-[trisubstitutedphenyl]-4-methyl Aniline Derivatives as Novel Anti-breast Cancer Agents

References

1. SalemM.G. Abu El-ataS.A. ElsayedE.H. MaliS.N. AlshwyehH.A. AlmaimaniG. AlmaimaniR.A. AlmasmoumH.A. AltwaijryN. Al-OlayanE. SaiedE.M. YoussefM.F. Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: Insights into cell cycle arrest, topoisomerase II, and EGFR activity.RSC Advances20231347330803309510.1039/D3RA06189B37954422
   [Google Scholar]
2. ChenF. WendlM.C. WyczalkowskiM.A. BaileyM.H. LiY. DingL. Moving pan-cancer studies from basic research toward the clinic.Nat. Can.20212987989010.1038/s43018‑021‑00250‑435121865
   [Google Scholar]
3. IslamM.S. RahiM.S. JahangirC.A. RahmanM.H. JerinI. AminR. HoqueK.M.F. RezaM.A. In vivo anticancer activity of Basella alba leaf and seed extracts against ehrlich’s ascites carcinoma (EAC) cell line.Evid. Based Complement. Alternat. Med.20182018153789610.1155/2018/1537896
   [Google Scholar]
4. HolohanC. Van SchaeybroeckS. LongleyD.B. JohnstonP.G. Cancer drug resistance: An evolving paradigm.Nat. Rev. Cancer2013131071472610.1038/nrc359924060863
   [Google Scholar]
5. MurphreeA.L. VillablancaJ.G. DeeganW.F. SatoJ.K. MalogolowkinM. FisherA. GomerC.J. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.Arch. Ophthalmol.1996114111348135610.1001/archopht.1996.01100140548005
   [Google Scholar]
6. GomtsyanA. Heterocycles in drugs and drug discovery.Chem. Heterocycl. Compd.201248171010.1007/s10593‑012‑0960‑z
   [Google Scholar]
7. HoelderS. ClarkeP.A. WorkmanP. Discovery of small molecule cancer drugs: Successes, challenges and opportunities.Mol. Oncol.20126215517610.1016/j.molonc.2012.02.00422440008
   [Google Scholar]
8. ZhangJ. YangP.L. GrayN.S. Targeting cancer with small molecule kinase inhibitors.Nat. Rev. Cancer200991283910.1038/nrc2559
   [Google Scholar]
9. Ramos-InzaS. AydilloC. SanmartínC. PlanoD. Thiazole moiety: An interesting scaffold for developing new antitumoral compounds.In: Heterocycles - Synthesis and Biological Activities; IntechOpen2019
   [Google Scholar]
10. WelschM.E. SnyderS.A. StockwellB.R. Privileged scaffolds for library design and drug discovery.Curr. Opin. Chem. Biol.201014334736110.1016/j.cbpa.2010.02.01820303320
    [Google Scholar]
11. WaziriI. IsaM.A. SonopoM. WilliamsD.B.G. MullerA. Synthesis, anti-microbial, toxicity and molecular docking studies of N-nitroso-N-phenylhydroxylamine (cupferron) and its derivatives.Bioorg. Med. Chem. Lett.20215212838110.1016/j.bmcl.2021.12838134571137
    [Google Scholar]
12. SrivastavaM. SinghJ. SinghS.B. TiwariK. PathakV.K. SinghJ. Synthesis of novel fused heterocycle-oxa-aza-phenanthrene and anthracene derivatives via sequential one-pot synthesis in aqueous micellar system.Green Chem.201214490190510.1039/c2gc16425f
    [Google Scholar]
13. XieZ. ChenX. JiangG. FanQ. YangH. LeZ. Photocatalytic synthesis of 2,4‐substituted quinazolines via a one‐pot, three‐component reaction under catalyst‐free conditions.J. Heterocycl. Chem.202461694895410.1002/jhet.4810
    [Google Scholar]
14. AroraS. NarayanP. OsgoodC.L. WedamS. ProwellT.M. GaoJ.J. ShahM. KrolD. WahbyS. RoyceM. GhoshS. PhilipR. IsonG. BermanT. BrusC. BloomquistE.W. FieroM.H. TangS. PazdurR. IbrahimA. Amiri-KordestaniL. BeaverJ.A.US. FDA drug approvals for breast cancer: A decade in review.Clin. Cancer Res.20222861072108610.1158/1078‑0432.CCR‑21‑260034711632
    [Google Scholar]
15. AnJ. PengC. XieX. PengF. New advances in targeted therapy of HER2-negative breast cancer.Front. Oncol.20221282843810.3389/fonc.2022.82843835311116
    [Google Scholar]
16. HermanowiczJ.M. SzymanowskaA. SiekluckaB. CzarnomysyR. PawlakK. BielawskaA. BielawskiK. KalafutJ. PrzybyszewskaA. SurazynskiA. Rivero-MullerA. MojzychM. PawlakD. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer.J. Enzyme Inhib. Med. Chem.202136153554810.1080/14756366.2021.187980333522320
    [Google Scholar]
17. MouradA.A.E. RizzkY.W. ZakiI. MohammedF.Z. El BeheryM. Synthesis and cytotoxicity screening of some synthesized hybrid nitrogen molecules as anticancer agents.J. Mol. Struct.2021124213072210.1016/j.molstruc.2021.130722
    [Google Scholar]
18. LeeC.C. ShihY.S. WuC.S. TsaiC.H. YehS.T. PengY.H. ChenK.J. Development of robust flexible OLED encapsulations using simulated estimations and experimental validations.J. Phys. D Appl. Phys.2012452727510210.1088/0022‑3727/45/27/275102
    [Google Scholar]
19. KourouK. ManikisG. MylonaE. Poikonen-SakselaP. MazzoccoK. Pat-HorenczykR. SousaB. Oliveira-MaiaA.J. MattsonJ. RozinerI. PettiniG. KondylakisH. MariasK. NuutinenM. KarademasE. SimosP. FotiadisD.I. Personalized prediction of one-year mental health deterioration using adaptive learning algorithms: A multicenter breast cancer prospective study.Sci. Rep.2023131705910.1038/s41598‑023‑33281‑137120428
    [Google Scholar]
20. MohammedF.Z. RizzkY.W. El-DeenI.M. GadE.M. El BeheryM. MahdyA.R.E. Discovery of 2‐Amino‐4H‐1, 3, 4‐thiadiazine‐5(6H)‐one derivatives and their in vitro antitumor investigation.ChemistrySelect202277e20210433310.1002/slct.202104333
    [Google Scholar]
21. GhoshD. EgbutaC. LoJ. Testosterone complex and non-steroidal ligands of human aromatase.J. Steroid Biochem. Mol. Biol.2018181111910.1016/j.jsbmb.2018.02.00929476820
    [Google Scholar]
22. ZakiI. AbdelhameidM.K. El-DeenI.M. Abdel WahabA.H.A. AshmawyA.M. MohamedK.O. Design, synthesis and screening of 1, 2, 4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line.Eur. J. Med. Chem.201815656357910.1016/j.ejmech.2018.07.00330025350
    [Google Scholar]
23. BlackburnH.L. EllsworthD.L. ShriverC.D. EllsworthR.E. Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.Cancer Causes Control201526331933210.1007/s10552‑014‑0519‑725554091
    [Google Scholar]
24. MohamedF.Z. RizzkY.W. Design, synthesis, cytotoxic screening and molecular docking studies of novel hybrid thiosemicarbazone derivatives as anticancer agents.Chem. Biodivers.20211812e210058010.1002/cbav.202100580
    [Google Scholar]
25. KheirollahiA. PordeliM. SafaviM. MashkouriS. Naimi-JamalM.R. ArdestaniS.K. Cytotoxic and apoptotic effects of synthetic benzochromene derivatives on human cancer cell lines.Naunyn Schmiedebergs Arch. Pharmacol.2014387121199120810.1007/s00210‑014‑1038‑525261336
    [Google Scholar]
26. ThomsenR. ChristensenM.H. MolDock: A new technique for high-accuracy molecular docking.J. Med. Chem.200649113315332110.1021/jm051197e16722650
    [Google Scholar]
27. ButtiR. DasS. GunasekaranV.P. YadavA.S. KumarD. KunduG.C. Receptor tyrosine kinases (RTKs) in breast cancer: Signaling, therapeutic implications and challenges.Mol. Cancer2018171118
    [Google Scholar]
28. TongL. WarrenT.C. KingJ. BetageriR. RoseJ. JakesS. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.J. Mol. Biol.1996256360161010.1006/jmbi.1996.01128604142
    [Google Scholar]
29. BeheryM.E. El-DeenI.M. El-ZendM.A. BarakatL.A.A. Design, synthesis and evaluation the bioactivities of novel 8 methoxy-1-azacoumarin-3-carboxamide derivatives as anti-diabetic agents.J. Mol. Struct.2023129413648610.1016/j.molstruc.2023.136486
    [Google Scholar]
30. El-ZendM.A. TantawyM.A. BarakatL.A.A. BarakatL.A. Synthesis and cytotoxicity screening of some synthesized coumarin and aza-coumarin derivatives as anticancer agents.Russ. J. Bioorganic Chem.202248238039010.1134/S106816202202011X
    [Google Scholar]
31. Ali BarakatL.A. El-DeenI.M. El-ZendM.A. El-BeheryM. In vitro cytotoxic investigation of some synthesized 1,6-disubstituted-1-azacoumarin derivatives as anticancer agents.Future Med. Chem.202315242289230710.4155/fmc‑2023‑026038047384
    [Google Scholar]